BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 21245083)

  • 1. Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.
    Kim MH; Kay DI; Rudra RT; Chen BM; Hsu N; Izumiya Y; Martinez L; Spencer MJ; Walsh K; Grinnell AD; Crosbie RH
    Hum Mol Genet; 2011 Apr; 20(7):1324-38. PubMed ID: 21245083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myogenic Akt signaling upregulates the utrophin-glycoprotein complex and promotes sarcolemma stability in muscular dystrophy.
    Peter AK; Ko CY; Kim MH; Hsu N; Ouchi N; Rhie S; Izumiya Y; Zeng L; Walsh K; Crosbie RH
    Hum Mol Genet; 2009 Jan; 18(2):318-27. PubMed ID: 18986978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice.
    Tjondrokoesoemo A; Schips T; Kanisicak O; Sargent MA; Molkentin JD
    Hum Mol Genet; 2016 Mar; 25(6):1192-202. PubMed ID: 26744329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.
    Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N
    Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
    Li D; Long C; Yue Y; Duan D
    Hum Mol Genet; 2009 Apr; 18(7):1209-20. PubMed ID: 19131360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice.
    Gallot YS; Straughn AR; Bohnert KR; Xiong G; Hindi SM; Kumar A
    Hum Mol Genet; 2018 Oct; 27(19):3449-3463. PubMed ID: 30010933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch.
    Dogra C; Changotra H; Wergedal JE; Kumar A
    J Cell Physiol; 2006 Sep; 208(3):575-85. PubMed ID: 16741926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice.
    Yue Y; Liu M; Duan D
    Mol Ther; 2006 Jul; 14(1):79-87. PubMed ID: 16563874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.
    Carberry S; Brinkmeier H; Zhang Y; Winkler CK; Ohlendieck K
    Int J Mol Med; 2013 Sep; 32(3):544-56. PubMed ID: 23828267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.
    Odom GL; Gregorevic P; Allen JM; Finn E; Chamberlain JS
    Mol Ther; 2008 Sep; 16(9):1539-45. PubMed ID: 18665159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
    Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.
    Alexander MS; Casar JC; Motohashi N; Vieira NM; Eisenberg I; Marshall JL; Gasperini MJ; Lek A; Myers JA; Estrella EA; Kang PB; Shapiro F; Rahimov F; Kawahara G; Widrick JJ; Kunkel LM
    J Clin Invest; 2014 Jun; 124(6):2651-67. PubMed ID: 24789910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling in stably regenerating skeletal muscle of dystrophin-deficient mdx mice.
    Boer JM; de Meijer EJ; Mank EM; van Ommen GB; den Dunnen JT
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S118-24. PubMed ID: 12206806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
    Crosbie RH; Barresi R; Campbell KP
    FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics analysis of sarcospan overexpression in mdx skeletal muscle reveals compensatory remodeling of cytoskeleton-matrix interactions that promote mechanotransduction pathways.
    McCourt JL; Stearns-Reider KM; Mamsa H; Kannan P; Afsharinia MH; Shu C; Gibbs EM; Shin KM; Kurmangaliyev YZ; Schmitt LR; Hansen KC; Crosbie RH
    Skelet Muscle; 2023 Jan; 13(1):1. PubMed ID: 36609344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression rate of myogenic regulatory factors and muscle growth factor after botulinum toxin A injection in the right masseter muscle of dystrophin deficient (mdx) mice.
    Botzenhart UU; Gerlach R; Gredes T; Rentzsch I; Gedrange T; Kunert-Keil C
    Adv Clin Exp Med; 2019 Jan; 28(1):11-18. PubMed ID: 30085421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.